Alexandra Phillippa Charrow, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hidradenitis Suppurativa | 7 | 2024 | 173 | 3.570 |
Why?
|
| Dermatology | 5 | 2023 | 914 | 1.630 |
Why?
|
| Acne Vulgaris | 4 | 2024 | 356 | 1.270 |
Why?
|
| Dermatologic Agents | 3 | 2024 | 308 | 1.140 |
Why?
|
| Isotretinoin | 3 | 2024 | 132 | 0.980 |
Why?
|
| Islam | 1 | 2024 | 70 | 0.880 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2024 | 278 | 0.770 |
Why?
|
| Transients and Migrants | 1 | 2023 | 162 | 0.710 |
Why?
|
| Pemphigoid, Bullous | 1 | 2021 | 114 | 0.680 |
Why?
|
| Alopecia | 1 | 2024 | 414 | 0.680 |
Why?
|
| Skin Ulcer | 1 | 2019 | 129 | 0.600 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2022 | 2420 | 0.580 |
Why?
|
| Dermatomyositis | 1 | 2019 | 256 | 0.530 |
Why?
|
| Hospitalists | 1 | 2019 | 294 | 0.510 |
Why?
|
| Refugees | 1 | 2023 | 595 | 0.480 |
Why?
|
| Clostridium Infections | 1 | 2021 | 557 | 0.470 |
Why?
|
| Communicable Diseases | 1 | 2023 | 877 | 0.470 |
Why?
|
| Smoking Cessation | 1 | 2024 | 2049 | 0.420 |
Why?
|
| Palliative Care | 3 | 2023 | 3570 | 0.390 |
Why?
|
| Crohn Disease | 1 | 2024 | 2275 | 0.380 |
Why?
|
| Autoantibodies | 1 | 2019 | 2118 | 0.360 |
Why?
|
| Phantom Limb | 2 | 2008 | 96 | 0.340 |
Why?
|
| Terminal Care | 1 | 2021 | 1750 | 0.330 |
Why?
|
| Amputation Stumps | 2 | 2008 | 38 | 0.330 |
Why?
|
| Hyperhidrosis | 1 | 2008 | 34 | 0.310 |
Why?
|
| Amputees | 1 | 2008 | 86 | 0.290 |
Why?
|
| Skin Diseases | 1 | 2016 | 1088 | 0.280 |
Why?
|
| Skin | 2 | 2023 | 4464 | 0.280 |
Why?
|
| Neuromuscular Agents | 1 | 2008 | 148 | 0.270 |
Why?
|
| Quality of Life | 3 | 2024 | 13286 | 0.250 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2008 | 229 | 0.240 |
Why?
|
| Immunoglobulin G | 1 | 2016 | 4540 | 0.230 |
Why?
|
| Autoimmune Diseases | 1 | 2016 | 2244 | 0.220 |
Why?
|
| Hair Removal | 1 | 2023 | 40 | 0.220 |
Why?
|
| Internship and Residency | 1 | 2023 | 5865 | 0.210 |
Why?
|
| Clindamycin | 1 | 2021 | 140 | 0.190 |
Why?
|
| Humans | 32 | 2024 | 758381 | 0.180 |
Why?
|
| Goiter | 1 | 2019 | 87 | 0.160 |
Why?
|
| Thyroiditis | 1 | 2019 | 86 | 0.160 |
Why?
|
| Minocycline | 1 | 2019 | 168 | 0.150 |
Why?
|
| Cardiology Service, Hospital | 1 | 2019 | 239 | 0.150 |
Why?
|
| Famous Persons | 1 | 2018 | 109 | 0.150 |
Why?
|
| Temperature | 1 | 2023 | 2219 | 0.140 |
Why?
|
| Government Programs | 1 | 2019 | 279 | 0.140 |
Why?
|
| Climate Change | 1 | 2023 | 487 | 0.140 |
Why?
|
| Papillomavirus Vaccines | 1 | 2022 | 497 | 0.130 |
Why?
|
| Mass Media | 1 | 2018 | 301 | 0.130 |
Why?
|
| Health Services Accessibility | 2 | 2024 | 5403 | 0.120 |
Why?
|
| Needs Assessment | 1 | 2020 | 1141 | 0.120 |
Why?
|
| Physicians, Primary Care | 1 | 2020 | 624 | 0.110 |
Why?
|
| Patient Admission | 1 | 2019 | 1372 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2024 | 10747 | 0.100 |
Why?
|
| Psoriasis | 1 | 2020 | 938 | 0.100 |
Why?
|
| Neck | 1 | 2016 | 731 | 0.090 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2024 | 1852 | 0.090 |
Why?
|
| Papillomavirus Infections | 1 | 2022 | 1612 | 0.090 |
Why?
|
| Head | 1 | 2016 | 921 | 0.090 |
Why?
|
| Curriculum | 1 | 2023 | 3717 | 0.080 |
Why?
|
| Academic Medical Centers | 1 | 2019 | 2751 | 0.080 |
Why?
|
| Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2008 | 52 | 0.080 |
Why?
|
| Fibrosis | 1 | 2016 | 2038 | 0.080 |
Why?
|
| Case-Control Studies | 3 | 2024 | 22031 | 0.080 |
Why?
|
| Injections, Intradermal | 1 | 2008 | 116 | 0.080 |
Why?
|
| Adult | 8 | 2024 | 219916 | 0.080 |
Why?
|
| Prosthesis Fitting | 1 | 2008 | 75 | 0.080 |
Why?
|
| Hospitals, Military | 1 | 2008 | 62 | 0.070 |
Why?
|
| Male | 10 | 2024 | 358742 | 0.070 |
Why?
|
| Young Adult | 4 | 2024 | 58808 | 0.070 |
Why?
|
| Smoking | 1 | 2024 | 9042 | 0.070 |
Why?
|
| Comorbidity | 1 | 2022 | 10495 | 0.070 |
Why?
|
| Chronic Disease | 1 | 2022 | 9266 | 0.070 |
Why?
|
| Biofeedback, Psychology | 1 | 2007 | 116 | 0.070 |
Why?
|
| Artificial Limbs | 1 | 2008 | 121 | 0.070 |
Why?
|
| Amputation, Traumatic | 1 | 2008 | 135 | 0.070 |
Why?
|
| Female | 8 | 2024 | 390316 | 0.070 |
Why?
|
| Clinical Trials as Topic | 1 | 2022 | 7985 | 0.070 |
Why?
|
| Immunization Programs | 1 | 2008 | 268 | 0.070 |
Why?
|
| Middle Aged | 5 | 2024 | 219560 | 0.060 |
Why?
|
| United States | 3 | 2024 | 72140 | 0.060 |
Why?
|
| Physician-Patient Relations | 1 | 2018 | 3242 | 0.060 |
Why?
|
| Arm | 1 | 2008 | 583 | 0.060 |
Why?
|
| Sex Factors | 1 | 2019 | 10505 | 0.060 |
Why?
|
| Retrospective Studies | 4 | 2023 | 80170 | 0.060 |
Why?
|
| Decision Making | 1 | 2018 | 3915 | 0.060 |
Why?
|
| Resilience, Psychological | 1 | 2012 | 772 | 0.060 |
Why?
|
| Clinical Competence | 1 | 2020 | 4775 | 0.060 |
Why?
|
| Emergency Service, Hospital | 1 | 2023 | 7810 | 0.060 |
Why?
|
| Blast Injuries | 1 | 2008 | 322 | 0.060 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 3362 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 3990 | 0.060 |
Why?
|
| Psychotherapy | 1 | 2013 | 1640 | 0.060 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2012 | 2197 | 0.060 |
Why?
|
| Incidence | 1 | 2021 | 21273 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 7403 | 0.050 |
Why?
|
| Mental Disorders | 2 | 2013 | 6803 | 0.050 |
Why?
|
| Insurance Carriers | 1 | 2023 | 155 | 0.050 |
Why?
|
| Anemia, Aplastic | 1 | 2003 | 228 | 0.050 |
Why?
|
| Antigens, CD34 | 1 | 2003 | 653 | 0.050 |
Why?
|
| Mental Health Services | 1 | 2013 | 1718 | 0.050 |
Why?
|
| Pain Measurement | 2 | 2008 | 3527 | 0.050 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 25953 | 0.050 |
Why?
|
| Physicians | 1 | 2018 | 4581 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2024 | 64379 | 0.040 |
Why?
|
| Lasers | 1 | 2023 | 952 | 0.040 |
Why?
|
| Risk Factors | 2 | 2022 | 73806 | 0.040 |
Why?
|
| Narration | 1 | 2018 | 219 | 0.030 |
Why?
|
| Inflammation | 1 | 2016 | 10719 | 0.030 |
Why?
|
| Developing Countries | 1 | 2008 | 2866 | 0.030 |
Why?
|
| Heart Failure | 1 | 2019 | 11594 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2008 | 3446 | 0.030 |
Why?
|
| Awareness | 1 | 2018 | 644 | 0.030 |
Why?
|
| Comprehension | 1 | 2018 | 619 | 0.030 |
Why?
|
| Pain | 1 | 2008 | 5065 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2008 | 4317 | 0.030 |
Why?
|
| Insurance Coverage | 1 | 2023 | 1933 | 0.030 |
Why?
|
| Adolescent | 5 | 2024 | 87888 | 0.020 |
Why?
|
| Vaccination | 1 | 2022 | 3356 | 0.020 |
Why?
|
| Family Relations | 1 | 2012 | 317 | 0.020 |
Why?
|
| Information Dissemination | 1 | 2018 | 1128 | 0.020 |
Why?
|
| Neoplasms | 1 | 2018 | 22030 | 0.020 |
Why?
|
| Medicaid | 1 | 2022 | 2807 | 0.020 |
Why?
|
| Inpatients | 1 | 2019 | 2551 | 0.020 |
Why?
|
| Health Status Disparities | 1 | 2019 | 1832 | 0.020 |
Why?
|
| Social Environment | 1 | 2012 | 1022 | 0.020 |
Why?
|
| Prevalence | 1 | 2024 | 15646 | 0.020 |
Why?
|
| Audiovisual Aids | 1 | 2007 | 99 | 0.020 |
Why?
|
| Boston | 1 | 2019 | 9304 | 0.020 |
Why?
|
| Self Concept | 1 | 2012 | 1041 | 0.020 |
Why?
|
| HIV Infections | 1 | 2012 | 17275 | 0.020 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2008 | 389 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2019 | 3261 | 0.020 |
Why?
|
| Research | 1 | 2012 | 1976 | 0.010 |
Why?
|
| Motivation | 1 | 2012 | 1996 | 0.010 |
Why?
|
| Social Support | 1 | 2012 | 2153 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2007 | 2048 | 0.010 |
Why?
|
| Child | 4 | 2013 | 79813 | 0.010 |
Why?
|
| Movement | 1 | 2007 | 1474 | 0.010 |
Why?
|
| Health Care Surveys | 1 | 2008 | 2432 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2003 | 1991 | 0.010 |
Why?
|
| Data Collection | 1 | 2008 | 3322 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2008 | 6353 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2019 | 23883 | 0.010 |
Why?
|
| Time Factors | 1 | 2019 | 39873 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 4459 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2003 | 2930 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 3774 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 58681 | 0.010 |
Why?
|
| Base Sequence | 1 | 2003 | 12436 | 0.010 |
Why?
|
| Prognosis | 1 | 2012 | 29558 | 0.010 |
Why?
|
| Aged | 2 | 2019 | 168217 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 20052 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2003 | 9405 | 0.000 |
Why?
|
| Infant | 1 | 2008 | 36054 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2008 | 42058 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2008 | 41252 | 0.000 |
Why?
|